首页> 外国专利> Agent for modulating excitatory synaptic transmission comprising a compound having alpha7 nicotinic acetylcholine receptor activation property

Agent for modulating excitatory synaptic transmission comprising a compound having alpha7 nicotinic acetylcholine receptor activation property

机译:用于调节兴奋性突触传递的药物,包括具有α7烟碱型乙酰胆碱受体活化特性的化合物

摘要

The present invention relates to an agent for modulating excitatory synaptic transmission which contains a compound having 7 nicotinic acetylcholine receptor activation property as an active ingredient, and the production of such an agent. It further relates to a pharmaceutical composition which contains such a compound together with a pharmaceutically acceptable carrier or excipient, and a method for modulating excitatory synaptic transmission which comprises administering such a composition. There is also provided a method for screening an agent for modulating excitatory synaptic transmission which comprises using 7 nicotinic acetylcholine receptor activation property as an index. The present invention is useful for the prophylaxis and/or treatment of cerebral diseases, including dementia, amnesia, manic-depressive psychosis, schizophrenia, Parkinson's disease and psychosomatic disease.
机译:本发明涉及一种调节兴奋性突触传递的药物,该药物含有具有7个烟碱乙酰胆碱受体活化特性的化合物作为活性成分,并涉及这种药物的生产。本发明还涉及含有这样的化合物和药学上可接受的载体或赋形剂的药物组合物,以及一种调节兴奋性突触传递的方法,该方法包括给予这种组合物。还提供了筛选用于调节兴奋性突触传递的试剂的方法,该方法包括使用7种烟碱乙酰胆碱受体活化特性作为指标。本发明可用于预防和/或治疗脑疾病,包括痴呆,健忘症,躁狂抑郁症,精神分裂症,帕金森氏病和心身疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号